📈 69% of S&P 500 stocks beating the index - a historic record! Pick the best ones with AI.See top stocks

Lykis Ltd (LYKI)

BSE
Currency in INR
Disclaimer
48.39
+0.36(+0.75%)
Closed
LYKI Scorecard
Full Analysis
Suffers from weak gross profit margins
Fair Value
Day's Range
48.0049.49
52 wk Range
39.5082.62
Bid/Ask
48.05 / 48.39
Prev. Close
48.03
Open
48.04
Day's Range
48-49.49
52 wk Range
39.5-82.62
Volume
10,142
Average Volume (3m)
35,806
1-Year Change
-17.86%
Fair Value
Unlock
Fair Value Upside
Unlock
LYKI Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock price often moves in the opposite direction of the market
Show more

Lykis Company Profile

Lykis Limited engages in the fast moving consumer goods (FMCG) business in India and internationally. The company provides personal care products including skin care products, such as creams, face wash, body oil, lotion, shower gel, masks, face and body scrub, hair removal cream, petroleum jelly, body butter, talc, intimate wash, petroleum jelly, and hand wash; hair care products comprising shampoo, spray, conditioner, base cream, hair food and relaxer, oil, detox mask, cleansing liquid, hair colour and milk, pomade, and gels; toothpaste; soaps; deodorant, perfume, and body mist; and baby cream, oil, shampoo, talc, wipes, and diaper. It also offers FMCG products, including biscuits and cookies; confectionery, such as candy, lollipops, and toffees; commodity products comprising hot pots, stock pots, utensils, footwear, liquor, and others; and other OTC products. The company provides its products under the Lykis, H&H, Rox, Bonita, Monami, Special, Lykon, Bentol, Stylo, Bon Fami, Calmon, Bon Dejeuner, Mellar, Bom Dia, Blue Fins, Bon Appetit, Senhorita, Polo Star, Leopard, Elephant, Carnoba, Classic, Maria, Spectra, Flite, Bahamas, Sparx, Metro, Cipro, Para, Dextrose and Water for Injection, Davigra, Dermogerme, A-DEM, Candicyl, Rectostop-HC, Nystatine, and Davimov brands. It also exports its products. Lykis Limited was formerly known as Greenline Tea & Exports Limited and changed its name to Lykis Limited in July 2012. The company was incorporated in 1984 and is headquartered in Mumbai, India.

Compare LYKI to Peers and Sector

Metrics to compare
LYKI
Peers
Sector
Relationship
P/E Ratio
26.5x40.7x11.8x
PEG Ratio
−0.350.520.03
Price/Book
3.0x3.6x1.5x
Price / LTM Sales
0.2x5.0x0.9x
Upside (Analyst Target)
-16.1%16.3%
Fair Value Upside
Unlock−13.3%8.2%Unlock

FAQ

What Is the Lykis (LYKI) Stock Price Today?

The Lykis stock price today is 48.39.

What Stock Exchange Does Lykis Trade On?

Lykis is listed and trades on the BSE stock exchange.

What Is the Stock Symbol for Lykis?

The stock symbol for Lykis is "LYKI."

What Is the Lykis Market Cap?

As of today, Lykis market cap is 939.70M.

What is Lykis Earnings Per Share?

The Lykis EPS is 1.81.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.